Trials / Completed
CompletedNCT03593681
Compare Fallopian Tube Cells Collected by Cytuity With Removed Ovarian/Tubal Tissue to Determine Presence of Malignancy
The nCYT Study: A Powered Study to Evaluate the Sensitivity and Specificity of Cytological Evaluation of Fallopian Tube Samples Collected by the Cytuity in Determining the Presence of Malignancy
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 150 (actual)
- Sponsor
- Boston Scientific Corporation · Industry
- Sex
- Female
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Prospective, multi-center, non-randomized study to assess the ability of the Cytuity device to collect cell samples from the fallopian tube that can be evaluated for the presence or absence of malignancy.
Conditions
- Fallopian Tube Cancer
- Ovarian Cancer
- Ovarian Neoplasms
- Ovary Cancer
- Fallopian Tube Neoplasms
- Fallopian Tube Adenocarcinoma
- High Grade Serous Carcinoma
- Peritoneal Carcinoma
- Peritoneal Neoplasms
- Adnexal Mass
- Ovarian Diseases
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Hysteroscopic cell sampling of the fallopian tube | Hysteroscopic fallopian tube biopsy |
Timeline
- Start date
- 2018-08-27
- Primary completion
- 2020-02-14
- Completion
- 2020-02-14
- First posted
- 2018-07-20
- Last updated
- 2021-01-20
- Results posted
- 2021-01-20
Locations
10 sites across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT03593681. Inclusion in this directory is not an endorsement.